2010 related articles for article (PubMed ID: 12831509)
41. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.
Lanas A; Sopeña F
Gastroenterol Clin North Am; 2009 Jun; 38(2):333-52. PubMed ID: 19446262
[TBL] [Abstract][Full Text] [Related]
42. Role of L-arginine in ibuprofen-induced oxidative stress and neutrophil infiltration in gastric mucosa.
Jiménez MD; Martín MJ; Alarcón de la Lastra C; Bruseghini L; Esteras A; Herrerías JM; Motilva V
Free Radic Res; 2004 Sep; 38(9):903-11. PubMed ID: 15621707
[TBL] [Abstract][Full Text] [Related]
43. Gastroduodenal damage due to drugs, alcohol and smoking.
Domschke S; Domschke W
Clin Gastroenterol; 1984 May; 13(2):405-36. PubMed ID: 6378444
[TBL] [Abstract][Full Text] [Related]
44. Effects of alendronate on gastric and duodenal mucosa.
Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
[TBL] [Abstract][Full Text] [Related]
45. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
Fromm D
Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
[TBL] [Abstract][Full Text] [Related]
46. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
Tomisato W; Tsutsumi S; Hoshino T; Hwang HJ; Mio M; Tsuchiya T; Mizushima T
Biochem Pharmacol; 2004 Feb; 67(3):575-85. PubMed ID: 15037209
[TBL] [Abstract][Full Text] [Related]
47. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.
Petruzzelli M; Vacca M; Moschetta A; Cinzia Sasso R; Palasciano G; van Erpecum KJ; Portincasa P
Clin Biochem; 2007 May; 40(8):503-10. PubMed ID: 17321514
[TBL] [Abstract][Full Text] [Related]
48. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
Lanza FL; Codispoti JR; Nelson EB
Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
[TBL] [Abstract][Full Text] [Related]
49. [Nonsteroidal-anti-inflammatory drugs and serious undesirable gastrointestinal effects].
Fabijanić D; Kardum D; Banić M; Fabijanić A
Lijec Vjesn; 2007; 129(6-7):205-13. PubMed ID: 18018712
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.
Fiorucci S; Antonelli E; Distrutti E; Rizzo G; Mencarelli A; Orlandi S; Zanardo R; Renga B; Di Sante M; Morelli A; Cirino G; Wallace JL
Gastroenterology; 2005 Oct; 129(4):1210-24. PubMed ID: 16230075
[TBL] [Abstract][Full Text] [Related]
51. Effects of commonly used non steroidal anti-inflammatory drugs on gastric mucosa. A clinical, endoscopic and histopathological study.
Misra R; Pandey H; Chandra M; Chandra M; Agarwal PK; Pandeya SN
J Assoc Physicians India; 1990 Sep; 38(9):636-8. PubMed ID: 2266080
[TBL] [Abstract][Full Text] [Related]
52. Sucralfate protection against gastrointestinal damage: possible role of prostanoids.
Ligumsky M; Karmeli F; Rachmilewitz D
Isr J Med Sci; 1986 Nov; 22(11):801-6. PubMed ID: 3098700
[TBL] [Abstract][Full Text] [Related]
53. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats.
Um SY; Chung MW; Kim KB; Kim SH; Oh JS; Oh HY; Lee HJ; Choi KH
Anal Chem; 2009 Jun; 81(12):4734-41. PubMed ID: 19462990
[TBL] [Abstract][Full Text] [Related]
54. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
[TBL] [Abstract][Full Text] [Related]
55. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.
Kirkova M; Kesiova M; Konstantinova S; Alexandrova A; Petrov L; Tsvetanova E; Todorov S
Auton Autacoid Pharmacol; 2007 Jan; 27(1):63-70. PubMed ID: 17199877
[TBL] [Abstract][Full Text] [Related]
56. [Pathogenic mechanism of NSAIDs-induced mucosal injury in lower gastrointestinal tract].
Beppu K; Osada T; Shibuya T; Watanabe S
Nihon Rinsho; 2011 Jun; 69(6):1083-7. PubMed ID: 21688632
[TBL] [Abstract][Full Text] [Related]
57. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
Miller K
Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
[TBL] [Abstract][Full Text] [Related]
58. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T
Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016
[TBL] [Abstract][Full Text] [Related]
59. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
60. Prevention of non-steroidal anti-inflammatory agents induced acute gastric mucosal lesions by carbonic anhydrase inhibitors. An endoscopic study.
Puscas I; Hajdu A; Buzás G; Bernáth Z
Acta Physiol Hung; 1989; 73(2-3):279-83. PubMed ID: 2596317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
